Ping An Biomedical Co., Ltd. PASW
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.10
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $4.8M | — | — |
| Cost of revenue | $4.7M | — | — |
| Gross profit | $133.4K | — | — |
| SG&A | $843.9K | — | — |
| Total operating expenses | $2.2M | — | — |
| Operating income | -$2.1M | — | — |
| Interest expense | $43.1K | — | — |
| Pre-tax income | -$2.1M | — | — |
| Income tax | $260.7K | — | — |
| Net income | -$1.8M | — | — |
| EPS, basic | -0.10 | — | — |
| EPS, diluted | -0.10 | — | — |
| Shares, diluted (wtd. avg.) | $18.5M | $18.0M | $18.0M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | $164.7K | $18.4K | — |
| Receivables | $2.4M | — | — |
| Inventory | $62.1K | — | — |
| Total current assets | $8.9M | — | — |
| Total assets | $9.6M | — | — |
| Accounts payable | $1.3M | — | — |
| Short-term debt | $1.4M | — | — |
| Total current liabilities | $3.2M | — | — |
| Total liabilities | $3.3M | — | — |
| Retained earnings | -$3.0M | — | — |
| Total equity | $6.4M | — | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating cash flow | -$902.9K | — | — |
| Depreciation and amortisation | $785 | — | — |
| Financing cash flow | $6.1M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-010078.
Others in SIC 2300
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LULU | lululemon athletica inc. | $10.62B | 7.6x | 4.9% |
| LEVI | LEVI STRAUSS & CO | $8.35B | 14.5x | 4.1% |
| COLM | COLUMBIA SPORTSWEAR CO | $2.95B | 17.8x | 0.9% |
| FIGS | FIGS, Inc. | $2.40B | 75.9x | 13.6% |
| UAA | Under Armour, Inc. | $2.25B | — | -3.8% |
| CRI | CARTERS INC | $1.23B | 13.3x | 1.9% |
| GIII | G III APPAREL GROUP LTD /DE/ | $1.17B | 18.4x | -7.0% |
| SGC | SUPERIOR GROUP OF COMPANIES, INC. | $203.0M | 27.7x | 0.1% |